Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding
about
A lectin isolated from bananas is a potent inhibitor of HIV replicationEffects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transportPathogenesis of human immunodeficiency virus infectionProximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopesHepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis CGlycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodiesInhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cellsHuman immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation.The influence of N-linked glycans on the molecular dynamics of the HIV-1 gp120 V3 loop.Functional contributions of carbohydrate on AIDS virus glycoproteinVariability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in FranceA source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virusEvolutionary interactions between N-linked glycosylation sites in the HIV-1 envelopeGlycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility.Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse modelInteraction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolateResistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases.Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors.Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated.Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection.Design of a non-glycosylated outer domain-derived HIV-1 gp120 immunogen that binds to CD4 and induces neutralizing antibodies.Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16.Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaquesPurification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus.The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.Engineering and exploitation of a fluorescent HIV-1 gp120 for live cell CD4 binding assaysEnzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected.epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals.Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding siteAntibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3.Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virusDifferential dependence on N-glycosylation of anthrax toxin receptors CMG2 and TEM8N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120
P2860
Q24629155-4D55F35C-0B4D-450C-8110-9B48B38827E5Q24633832-07F5CA2A-83A5-42F7-B308-FE6A8AF9C09DQ24634681-5762FF0D-A845-48AD-927A-BE6A0C205906Q24645308-BCEA382D-E771-4D0E-B5DF-7052F44C75F1Q27486537-758C5C06-3879-4EF9-B508-2A71AD479288Q28263932-DA57C5E3-CA5C-4398-920F-1EC95E390D08Q28369132-0DAB8BAF-249B-42E3-B882-A0E9C51E7FB5Q28646878-7C7B29EF-FD12-4D5B-A040-934A11D4B41FQ30356350-56A981C9-CCEA-4713-9EAA-A7E05A5E36BDQ30397572-A40082F7-9C65-40AE-9130-4E8EE88A2F90Q30417537-89F2BC59-86F0-44E1-B8D5-21C4463BBAF1Q30425683-250C862A-658B-4A26-B9E2-E262BDF0CC34Q30452152-131B7CBE-8160-4816-8694-700252C09B28Q33269794-783BE1B4-81C3-43B6-B221-47ABDB275BAEQ33323199-9FC8BF90-9ABA-4C26-BEA8-04C4E71DB6EAQ33676640-949C53FC-8D7D-4BC1-8702-77844D815D69Q33788874-6E852D3A-42B5-4823-9828-C32F1A5EBA2AQ33827027-E2B778F2-70A0-4BFA-AF0D-0B9BB49D2871Q33842989-2E4652A3-A703-4053-A42B-96298CDB91BCQ33843345-88B50402-32CB-46C2-89A6-E2181B59C627Q33851094-4A534E0B-771D-490F-9303-A39730D835C7Q33876152-6EDFB6BD-77AB-42E8-888A-DC8450271737Q33967039-342467EC-145F-4166-AB72-D6E9A37CA620Q34034659-682154DA-278D-4204-AE7E-D41D25B5B91AQ34094476-D76BA3B7-E32C-4466-B7BF-043DE27BF460Q34178201-6FDE9551-631C-445E-9D4C-F72325D82EFBQ34301728-BE04E250-F6D5-4B28-A977-6063921A696CQ34332284-8AF0949D-1EE0-4C2F-A1A2-BBED40E8D763Q34341843-A978D155-5484-4E24-BE2B-CF2694BB02F6Q34555891-3B44FAC8-F746-4FCB-84C7-C2890F9B578EQ34998032-0D27FEA4-EA08-49BC-B395-5674672A39F9Q35070898-A4A92C47-611F-4507-BE8B-389C473BE579Q35076987-0ACB27EC-EA29-45A6-855F-F91745EFBF33Q35192660-E422C090-0340-448F-8559-B97FA1ECC25EQ35192937-105CF7BA-E383-44C8-91AF-DA2AB12A96FFQ35227014-1DE81C5D-8F3C-4442-B7F6-24865DE0DC27Q35542887-9D6B44F5-F541-4CF4-B4EA-AB3D0A47513BQ35568986-59162D20-CE10-4E33-A56A-C85EDDDEF1B7Q35579665-0BDCEC7B-15D0-4271-BC08-A95D5C3FE151Q35870879-6355A7A2-647D-4577-B228-DEB2306F2D1E
P2860
Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Glycosylation is necessary for ...... ncy virus gp120 in CD4 binding
@ast
Glycosylation is necessary for ...... ncy virus gp120 in CD4 binding
@en
Glycosylation is necessary for ...... ncy virus gp120 in CD4 binding
@nl
type
label
Glycosylation is necessary for ...... ncy virus gp120 in CD4 binding
@ast
Glycosylation is necessary for ...... ncy virus gp120 in CD4 binding
@en
Glycosylation is necessary for ...... ncy virus gp120 in CD4 binding
@nl
prefLabel
Glycosylation is necessary for ...... ncy virus gp120 in CD4 binding
@ast
Glycosylation is necessary for ...... ncy virus gp120 in CD4 binding
@en
Glycosylation is necessary for ...... ncy virus gp120 in CD4 binding
@nl
P2093
P2860
P1433
P1476
Glycosylation is necessary for ...... ncy virus gp120 in CD4 binding
@en
P2093
P2860
P304
P407
P577
1993-01-01T00:00:00Z